Papilla cannulation in ERCP through remote or in-person training: study protocol for a single-centre randomised controlled trial (SmartERCP-Trial)”

Inside the human body, the bile and pancreatic ducts are narrow, winding tunnels that carry digestive fluids. When these passages become blocked by stones or swelling, doctors must perform a delicate procedure called an endoscopic retrograde cholangiopancreatography, or ERCP, to clear them. This is not a simple task; it requires threading a flexible tube through the digestive system to reach a tiny opening called the papilla, where the ducts meet the intestine. The doctor must then guide a wire through this opening with extreme precision. Because the procedure is so difficult, it usually demands that a highly experienced specialist stands right next to the trainee, watching every move and offering immediate guidance. However, in many parts of the world, especially in rural areas or during off-hours, such an expert is not available. This shortage creates a gap in care: patients may wait too long for treatment, or trainees may struggle to learn without a mentor nearby.

To bridge this gap, a team of researchers at Helios Hospital in Schwerin, Germany, set out to test a modern solution. They wanted to know if a trainee could learn and perform this complex procedure just as well and safely when guided remotely through smart glasses, rather than by a teacher standing in the room. The study, known as the SmartERCP-Trial, is a carefully planned experiment designed to see if technology can replace physical presence without compromising patient safety or the quality of training. The researchers did not simply guess; they designed a rigorous test where doctors in training would perform the procedure under one of two conditions: either with an expert standing right beside them, or with an expert watching a live video feed from a neighboring room through the trainee's smart glasses.

The study focuses on a specific moment in the procedure: the time it takes to successfully thread a wire through the natural opening of the papilla. This is the critical first step that determines whether the rest of the procedure can proceed. The researchers recruited doctors who were already training to become gastroenterologists and paired them with experienced instructors. Each patient scheduled for the procedure was randomly assigned to one of the two groups. In the control group, the instructor stood in the room, offering direct, face-to-face advice. In the experimental group, the instructor sat in an adjacent room, watching the trainee's view through the smart glasses and speaking instructions over a live audio connection. The instructor in the neighboring room could see exactly what the trainee saw and could intervene immediately if the situation became dangerous, even stepping in to take over the procedure if necessary.

The goal was to see if the remote guidance was "non-inferior," meaning it was not worse than the traditional method by any significant amount. The researchers calculated that they would need about 85 patients in each group to get a clear answer. They defined success not just by whether the wire got through, but by how long it took. They allowed for a small margin of difference, deciding that if the remote group took up to five minutes longer on average, the method would still be considered acceptable. This timeframe accounts for the slight delay that might occur when communicating through a screen. The study also closely monitored for any complications, such as inflammation of the pancreas or infection, which can happen after this type of procedure. These risks were tracked for two days after the surgery to ensure that the remote method did not put patients in greater danger.

While the study protocol was written with the expectation that the results would show the remote method works, the paper itself is a plan for how the research will be conducted, not a report of the final numbers. The authors acknowledge that there are potential hurdles. For instance, if the video connection fails or if the trainee feels too uncomfortable to continue, the instructor would have to step in and take over, which would count as a change in the plan. They also noted that the difficulty of the procedure can vary from patient to patient, and they made sure to record these details to ensure a fair comparison. The researchers believe that if this method proves successful, it could allow expert doctors to guide trainees in remote hospitals or during the night, ensuring that high-quality care is available whenever it is needed, regardless of where the expert is physically located.

The design of the trial is built on the idea that the skill of cannulation—the act of threading the wire—is the most measurable part of the learning curve. By focusing on this single, precise action, the researchers hope to isolate the effect of the teaching method. The study is being conducted with strict safety measures, including a system where the instructor can switch from remote to in-person assistance at any moment. This ensures that the patient is never left without an expert's direct control if the situation demands it. The researchers are also careful to keep the process unbiased; while the doctors know which method they are using, the patients do not, and the people analyzing the data later will not know which group each patient belonged to. This approach helps ensure that the results reflect the true effectiveness of the technology rather than the expectations of the people involved.

Ultimately, this work represents a step toward modernizing medical training in a field where hands-on guidance has traditionally been the only option. If the results confirm that smart glasses can provide guidance as effective as a teacher standing in the room, it could change how medical specialists are trained and how emergency procedures are managed in areas far from major medical centers. The study does not claim to have solved the problem of specialist shortages, but it offers a concrete way to test whether technology can fill that void. By measuring time, safety, and success rates with the same rigor used in any major medical trial, the researchers aim to provide clear evidence that can either support or refute the use of telemedicine in this high-stakes environment. The findings will eventually be shared with the medical community to help decide if this new way of teaching is ready for widespread use.